10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,434,305 | +126.9% | 204,468 | +207.1% | 0.02% | +100.0% |
| Q2 2023 | $3,717,827 | +84.1% | 66,580 | +83.9% | 0.01% | +175.0% |
| Q1 2023 | $2,019,598 | +313.4% | 36,200 | +170.0% | 0.00% | +100.0% |
| Q4 2022 | $488,478 | -37.1% | 13,405 | +31.4% | 0.00% | -33.3% |
| Q1 2022 | $776,000 | -44.1% | 10,200 | +43.8% | 0.00% | -40.0% |
| Q2 2021 | $1,389,000 | +168.7% | 7,094 | +148.5% | 0.01% | +150.0% |
| Q1 2021 | $517,000 | -60.7% | 2,855 | -69.3% | 0.00% | -66.7% |
| Q4 2020 | $1,317,000 | +2.1% | 9,301 | -10.1% | 0.01% | -14.3% |
| Q3 2020 | $1,290,000 | – | 10,345 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |